跳至主要内容
临床试验/TCTR20210923001
TCTR20210923001已完成不适用

Prospective study and cost-effectiveness analysis of the outcomes of advanced pain interventions in Thailand)

Mahidol University0 个研究点目标入组 50 人开始时间: 2021年9月23日最近更新:

试验速览

阶段
不适用
状态
已完成
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
7 Years 至 N/A (No limit)(—)
性别
All

入选标准

  • 1) The patients were more than 7 years old
  • 2) The patients suffered from chronic intractable pain from FBSS, PVD or neuropathic pain
  • 3) The patients reported no satisfactory response to previous treatment defined by a pain score (numeric rating scale or NRS) of at least 5 out of 10 for at least 2 years, despite physical therapy, appropriate regimen of pain medication (gabapentin dose of more than 900 mg/day or pregabalin more than 150 mg/day and two or more other pain medications), other pain interventions or surgery.
  • SCS+CMM group
  • Any patients who underwent a successful SCS trial and subsequent implantation.

排除标准

  • 1. Refusal to participate in the study
  • 2. Pain due to cancer 3. Difficulty of communication or poor literacy of Thai language

研究者

相似试验